Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in Children and Adolescents
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
Purpose of study: This phase I/II trial is to evaluate the safety and feasibility of
TCRαβ-depleted graft from haploidentical family donors in treating children and adolescents
with malignant or non-malignant diseases.